Day Zero Diagnostics

Addressing the growing threat of antibiotic-resistance

Boston, MA

About the company

Diagnostics company that is leveraging next gen sequencing and machine learning (ML) to address the growing threat of antibiotic-resistance. The company’s name comes from their mission to provide species ID and antibiotic resistance profile on the first day, delivering a full diagnosis in less than 8 hours. The company is developing an IVD product for point of care testing use in hospitals.